Doctor profile · Federal record
Dr. VIRGINIA LUPARELLO-RAGUSA, FNP
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · RHINEBECK, NY
- NPI 1942947734
- Accepts Medicare
- MIPS 89.1 / 100 · 2023
- 5 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6511 SPRING BROOK AVE STE 101
RHINEBECK, NY 125723709
(845) 471-3545 - Mailing address
-
9 AVONLEE LN
PAWLING, NY 125642167
Credentials & registration
- NPI registered
- May 2022 — 4 yrs on file
- Profile last updated
- March 29, 2023
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- New York #349202
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942947734. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
98
Distinct HCPCS
2
Medicare allowed
$11,377
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 73 | 49 | $116 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 24 | $118 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 49. This provider delivers 2.0× the peer median.Open Payments
Industry payments received
All-time total
$1,582
Transactions
36
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $681.53 | |
| AstraZeneca Pharmaceuticals LP | 8 | $210.94 | |
| Amgen Inc. | 1 | $125.00 | |
| BeiGene USA, Inc. | 1 | $108.05 | |
| ABBVIE INC. | 4 | $101.67 | |
| GENZYME CORPORATION | 2 | $70.21 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $59.27 | |
| Celgene Corporation | 2 | $43.12 | |
| Daiichi Sankyo Inc. | 2 | $42.83 | |
| Gilead Sciences, Inc. | 1 | $30.83 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25.61 | |
| JAZZ PHARMACEUTICALS INC. | 1 | $24.66 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $24.54 | |
| Karyopharm Therapeutics Inc. | 1 | $17.76 | |
| Incyte Corporation | 1 | $15.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
118
Patients
0
Total drug cost
$352,185
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Revlimid (Lenalidomide) | Brand | 20 | 0 | $339,893 |
| Anastrozole | Generic | 19 | 0 | $388 |
| Eliquis (Apixaban) | Brand | 19 | 0 | $11,014 |
| Dexamethasone | Generic | 18 | 0 | $290 |
| Hydroxyurea | Generic | 16 | 0 | $289 |
| Prednisone | Generic | 13 | 0 | $50 |
| Prochlorperazine Maleate | Generic | 13 | 0 | $261 |